http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 14 Jul 2026 06:59:47 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Microbot+Medical+%28MBOT%29/26764564.html <p>H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $12.00 price target on Microbot Medical (NASDAQ: MBOT).</p><p>The analyst commented: "Last week, Microbot Medical reported over 100% growth in revenue and new customers for 2Q26 compared to 1Q26, following the commencement of full market release of the LIBERTY System on April 13, 2026. Notably, health systems in several key markets adopted the system during 2Q26, including leading health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania. In addition, the company entered into an agreement with Lovell Government Services Inc. to serve federal healthcare systems. It is noteworthy that health systems http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Microbot+Medical+%28MBOT%29/26764564.html Tue, 14 Jul 2026 06:59:47 -0400 MBOT http://www.streetinsider.com/Corporate+News/Microbot+Medical+reports+over+100%25+revenue+growth+in+Q2+2026/26739232.html <p>Microbot Medical Inc. (NASDAQ: MBOT) reported revenue and new customer growth of more than 100% in the second quarter ended June 30, 2026, compared to the first quarter ended March 31, 2026, according to a company statement.</p><p>The company attributed the growth to the full market release of its LIBERTY Endovascular Robotic System, which commenced April 13, 2026. Health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania adopted the system during the quarter.</p><p>Health systems that had previously adopted the LIBERTY System during its limited market release also increased procedure volume in the second quarter, which the company said was due to http://www.streetinsider.com/Corporate+News/Microbot+Medical+reports+over+100%25+revenue+growth+in+Q2+2026/26739232.html Tue, 07 Jul 2026 08:33:13 -0400 MBOT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jul+07/26739168.html si-local-file:///var/storage/secattach/20260707/26739168.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jul+07/26739168.html Tue, 07 Jul 2026 08:30:00 -0400 MBOT O.00647163 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jul+07/26739168.html si-local-file:///var/storage/secattach/20260707/26739168.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jul+07/26739168.html Tue, 07 Jul 2026 08:30:00 -0400 MBOT O.00647163 http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html <p align="center"><em>The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April</em></p> <p align="center"><em>Heightened awareness generating interest from leading health systems across the U.S. as Company plans to increase its U.S. sales territories from 8 to 12 and enter international markets by the end of 2026 </em></p> <p align="justify">HINGHAM, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html Tue, 07 Jul 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html <p align="center"><em>The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April</em></p> <p align="center"><em>Heightened awareness generating interest from leading health systems across the U.S. as Company plans to increase its U.S. sales territories from 8 to 12 and enter international markets by the end of 2026 </em></p> <p align="justify">HINGHAM, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html Tue, 07 Jul 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html <p align="center"><em>The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April</em></p> <p align="center"><em>Heightened awareness generating interest from leading health systems across the U.S. as Company plans to increase its U.S. sales territories from 8 to 12 and enter international markets by the end of 2026 </em></p> <p align="justify">HINGHAM, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html Tue, 07 Jul 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html <p align="center"><em>The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April</em></p> <p align="center"><em>Heightened awareness generating interest from leading health systems across the U.S. as Company plans to increase its U.S. sales territories from 8 to 12 and enter international markets by the end of 2026 </em></p> <p align="justify">HINGHAM, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Reports+Over+100%25+Revenue+and+Customer+Growth+as+Procedure+Volume+Also+Rises+in+the+Second+Quarter+of+2026/26739099.html Tue, 07 Jul 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Corporate+News/Microbot+Medical+signs+Sanmina+deal+to+expand+LIBERTY+system+output/26710202.html <p>Microbot Medical Inc. (NASDAQ: MBOT) has signed a Letter of Agreement with Sanmina Corporation to manufacture its LIBERTY Endovascular Robotic System, according to a company statement released June 30, 2026.</p> <p>The LIBERTY System is FDA-cleared as a single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot said the agreement with Sanmina, a global contract manufacturer with sites across multiple regions, is intended to serve as a second manufacturing site, diversify production capabilities, and support cost reduction efforts.</p> <p>The company said it expects the arrangement to improve operating efficiencies, lower costs, and expand gross margins. Microbot cited growing utilization among accounts across http://www.streetinsider.com/Corporate+News/Microbot+Medical+signs+Sanmina+deal+to+expand+LIBERTY+system+output/26710202.html Tue, 30 Jun 2026 08:30:40 -0400 MBOT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+30/26710213.html si-local-file:///var/storage/secattach/20260630/26710213.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+30/26710213.html Tue, 30 Jun 2026 08:30:00 -0400 MBOT O.00647163 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+30/26710213.html si-local-file:///var/storage/secattach/20260630/26710213.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+30/26710213.html Tue, 30 Jun 2026 08:30:00 -0400 MBOT O.00647163 http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html <p><strong>Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansion</strong></p><p align="justify">HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of Agreement (LOA) with Sanmina Corporation, a leading global integrated manufacturing solutions provider, to manufacture the LIBERTY System, the only FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html Tue, 30 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html <p><strong>Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansion</strong></p><p align="justify">HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of Agreement (LOA) with Sanmina Corporation, a leading global integrated manufacturing solutions provider, to manufacture the LIBERTY System, the only FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html Tue, 30 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html <p><strong>Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansion</strong></p><p align="justify">HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of Agreement (LOA) with Sanmina Corporation, a leading global integrated manufacturing solutions provider, to manufacture the LIBERTY System, the only FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html Tue, 30 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html <p><strong>Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansion</strong></p><p align="justify">HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of Agreement (LOA) with Sanmina Corporation, a leading global integrated manufacturing solutions provider, to manufacture the LIBERTY System, the only FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Increases+Manufacturing+Capacity+as+Demand+for+the+LIBERTY%C2%AE+System+Rises%3B+Enters+into+Strategic+Agreement+with+Sanmina%2C+a+Global+Manufacturing+Leader/26710151.html Tue, 30 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html <p><strong>Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit</strong></p><p align="justify">HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics Technology (SRT), which recognizes companies with outstanding technological and commercial progress through highly innovative, groundbreaking technologies with the potential for broad healthcare impact.¹ SRT, a leading platform for surgical robotics news, together with QNX, recognizes outstanding organizations, individuals, and technologies across the surgical robotics sector.</p> http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html Thu, 25 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html <p><strong>Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit</strong></p><p align="justify">HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics Technology (SRT), which recognizes companies with outstanding technological and commercial progress through highly innovative, groundbreaking technologies with the potential for broad healthcare impact.¹ SRT, a leading platform for surgical robotics news, together with QNX, recognizes outstanding organizations, individuals, and technologies across the surgical robotics sector.</p> http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html Thu, 25 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html <p><strong>Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit</strong></p><p align="justify">HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics Technology (SRT), which recognizes companies with outstanding technological and commercial progress through highly innovative, groundbreaking technologies with the potential for broad healthcare impact.¹ SRT, a leading platform for surgical robotics news, together with QNX, recognizes outstanding organizations, individuals, and technologies across the surgical robotics sector.</p> http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html Thu, 25 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html <p><strong>Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit</strong></p><p align="justify">HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics Technology (SRT), which recognizes companies with outstanding technological and commercial progress through highly innovative, groundbreaking technologies with the potential for broad healthcare impact.¹ SRT, a leading platform for surgical robotics news, together with QNX, recognizes outstanding organizations, individuals, and technologies across the surgical robotics sector.</p> http://www.streetinsider.com/Globe+Newswire/Microbot+Medical%C2%AE+Wins+Surgical+Robotics+Industry+Award+for+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26688718.html Thu, 25 Jun 2026 08:30:00 -0400 MBOT MBOT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+25/26688782.html si-local-file:///var/storage/secattach/20260625/26688782.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+25/26688782.html Thu, 25 Jun 2026 08:30:00 -0400 MBOT O.00647163 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+25/26688782.html si-local-file:///var/storage/secattach/20260625/26688782.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+25/26688782.html Thu, 25 Jun 2026 08:30:00 -0400 MBOT O.00647163 http://www.streetinsider.com/Corporate+News/Microbot+Medical+gains+first+Pennsylvania+health+system+customer/26676470.html <p>Microbot Medical Inc. (NASDAQ: MBOT) announced that a Pennsylvania-based academic health system has adopted its LIBERTY Endovascular Robotic System, marking the first adoption of the device in that state, according to a company press release.</p><p>The unnamed health system operates multiple hospitals and multispecialty centers serving patients in Pennsylvania and New Jersey. Microbot said the company now has accounts across seven states in the eastern U.S., with multiple hospitals within those health systems having adopted the LIBERTY System.</p><p>The Pennsylvania customer is the second Microbot account with facilities spanning two states. A New York City-based customer also has medical facilities in New http://www.streetinsider.com/Corporate+News/Microbot+Medical+gains+first+Pennsylvania+health+system+customer/26676470.html Tue, 23 Jun 2026 08:31:21 -0400 MBOT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+23/26676468.html si-local-file:///var/storage/secattach/20260623/26676468.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+23/26676468.html Tue, 23 Jun 2026 08:31:00 -0400 MBOT O.00647163 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+23/26676468.html si-local-file:///var/storage/secattach/20260623/26676468.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Microbot+Medical+Inc.+++++For%3A+Jun+23/26676468.html Tue, 23 Jun 2026 08:31:00 -0400 MBOT O.00647163 http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Announces+First+Health+System+in+Pennsylvania+to+Adopt+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26676402.html <p align="center"><em>Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S.</em></p> <p align="center"><em>The Company now has multiple accounts and hospitals that have adopted the LIBERTY System across seven states in the U.S.</em></p> <p align="justify">HINGHAM, Mass., June 23, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY^® Endovascular Robotic System, announced that a globally recognized academic center headquartered in Pennsylvania is the first in the state to adopt the LIBERTY System, allowing the Company to further expand its presence in the Northeast U.S., joining http://www.streetinsider.com/Press+Releases/Microbot+Medical%C2%AE+Announces+First+Health+System+in+Pennsylvania+to+Adopt+the+LIBERTY%C2%AE+Endovascular+Robotic+System/26676402.html Tue, 23 Jun 2026 08:30:00 -0400 MBOT MBOT